LCD L39007: MolDX: Molecular Biomarkers to Risk-Stratify Patients at Increased Risk for Prostate Cancer — Noridian
Policy LCD-L39007 · Oncology
New LCD for prostate cancer risk-stratification impacts billing.
Code intelligence
R97.2 reimbursement alerts
Policy changes, MAC LCD updates, and CMS guidance matched to code R97.2.
Elevated code riskView ICD-10 detail
Signal breakdown
2 shown · 2 total in platform
Risk: Elevated
0
Critical
0%
1
High
50%
1
Routine
50%
0
Low
0%
New this month
—
alerts added in last 30 days
Effective soon
—
no upcoming deadlines
High
LCD L39686: MolDX: Gene Expression Profile Tests for Decision-Making in Castration Resistant and Metastatic Prostate Cancers — Noridian
Policy LCD-L39686 · Oncology
Key updates for prostate cancer decision-making tests.
Audit documentation
Building an audit file that includes R97.2?
The Tripwire Audit Pack exports 12 months of Oncology policy-change history — every alert with a link to its government source document, as a formatted PDF for compliance distribution plus a machine-readable CSV. Delivered automatically after payment. No account, no call.
Get the Oncology audit pack — $349One-time purchase · not a subscription